Health news Teva and Viatris win US appeal in Parkinson’s disease drug patent fight; Novavax Cut Costs by $50 Million, Plans to Cut More, CEO Says, and More [Beuzz] Here is a summary of health news briefs. Teva and Viatris win US appeal in Parkinson’s disease drug patent fight…